Adirondack Trust Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$916K Buy
2,529
+5
+0.2% +$1.71K 0.27% 70
2026
Q1
$888K Sell
2,524
-7
-0.3% -$2.5K 0.3% 68
2025
Q4
$828K Sell
2,531
-110
-4% -$34.9K 0.27% 73
2025
Q3
$745K Sell
2,641
-233
-8% -$67.6K 0.25% 77
2025
Q2
$802K Sell
2,874
-42
-1% -$11.9K 0.29% 72
2025
Q1
$908K Sell
2,916
-62
-2% -$18.3K 0.36% 65
2024
Q4
$776K Buy
2,978
+88
+3% +$26.1K 0.3% 71
2024
Q3
$931K Buy
2,890
+31
+1% +$10.1K 0.36% 65
2024
Q2
$893K Sell
2,859
-10
-0.3% -$2.94K 0.36% 63
2024
Q1
$816K Buy
2,869
+21
+0.7% +$6.14K 0.34% 68
2023
Q4
$780K Buy
2,848
+35
+1% +$9.54K 0.34% 65
2023
Q3
$756K Buy
2,813
+123
+5% +$30.7K 0.38% 64
2023
Q2
$630K Sell
2,690
-13
-0.5% -$3.02K 0.29% 75
2023
Q1
$653K Buy
2,703
+26
+1% +$6.38K 0.33% 73
2022
Q4
$703K Hold
2,677
0.36% 70
2022
Q3
$603K Buy
2,677
+39
+1% +$9.45K 0.34% 71
2022
Q2
$642K Buy
2,638
+106
+4% +$26K 0.34% 69
2022
Q1
$612K Buy
2,532
+774
+44% +$178K 0.29% 74
2021
Q4
$395K Buy
1,758
+25
+1% +$5.28K 0.19% 93
2021
Q3
$359K Buy
1,733
+26
+2% +$5.98K 0.17% 97
2021
Q2
$416K Hold
1,707
0.21% 88
2021
Q1
$425K Buy
1,707
+450
+36% +$107K 0.23% 84
2020
Q4
$303K Sell
1,257
-5
-0.4% -$1.15K 0.18% 86
2020
Q3
$320K Hold
1,262
0.21% 84
2020
Q2
$308K Hold
1,262
0.2% 84
2020
Q1
$256K Sell
1,262
-1,040
-45% -$227K 0.21% 80
2019
Q4
$497K Buy
2,302
+1,060
+85% +$234K 0.33% 69
2019
Q3
$240K Buy
1,242
+24
+2% +$4.61K 0.17% 86
2019
Q2
$224K Hold
1,218
0.16% 89
2019
Q1
$218K Sell
1,218
-160
-12% -$30.6K 0.15% 91
2018
Q4
$268K Hold
1,378
0.21% 79
2018
Q3
$286K Buy
1,378
+17
+1% +$3.35K 0.19% 84
2018
Q2
$251K Hold
1,361
0.18% 87
2018
Q1
$237K Sell
1,361
-54
-4% -$9.91K 0.17% 89
2017
Q4
$246K Hold
1,415
0.18% 81
2017
Q3
$264K Sell
1,415
-15
-1% -$2.66K 0.21% 76
2017
Q2
$246K Sell
1,430
-40
-3% -$6.51K 0.2% 80
2017
Q1
$241K Buy
1,470
+135
+10% +$22.4K 0.17% 87
2016
Q4
$195K Sell
1,335
-105
-7% -$15.8K 0.14% 94
2016
Q3
$240K Buy
1,440
+25
+2% +$4.23K 0.17% 86
2016
Q2
$215K Hold
1,415
0.15% 93
2016
Q1
$212K Hold
1,415
0.16% 92
2015
Q4
$216K Hold
1,415
0.17% 83
2015
Q3
$196K Buy
1,415
+80
+6% +$12.6K 0.16% 93
2015
Q2
$205K Buy
1,335
+25
+2% +$4K 0.15% 92
2015
Q1
$209K Buy
1,310
+310
+31% +$48.8K 0.16% 92
2014
Q4
$159K Sell
1,000
-25
-2% -$3.9K 0.12% 104
2014
Q3
$144K Buy
1,025
+115
+13% +$15K 0.11% 103
2014
Q2
$108K Buy
910
+110
+14% +$12.7K 0.08% 107
2014
Q1
$99K Sell
800
-512
-39% -$62.1K 0.08% 111
2013
Q4
$150K Hold
1,312
0.12% 96
2013
Q3
$147K Hold
1,312
0.13% 91
2013
Q2
$129K Buy
+1,312
New +$136K 0.12% 95

Other funds holding AMGN

Adirondack Trust Company's AMGN Position: Q2 2026 in Review

Adirondack Trust Company increased its Amgen (AMGN) stake by 0.2% in Q2 2026, buying an estimated $1.71K and bringing the position to 2,529 shares worth $916K. The position accounts for 0.27% of the portfolio, ranked #70.

Adirondack Trust Company first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $931K in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Adirondack Trust Company held 2,529 shares of Amgen worth $916K as of Q2 2026.
  • Adirondack Trust Company bought 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up 0.27% of Adirondack Trust Company's portfolio in Q2 2026, its #70 holding.
  • Adirondack Trust Company first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Adirondack Trust Company's Amgen position peaked at $931K in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.